Fri, May 10, 2024

David Amsellem Reiterated (XERS) at Buy with Decreased Target to $3 on, May 10th, 2024

David Amsellem of Piper Sandler, Reiterated "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Decreased Target from $4 to $3 on, May 10th, 2024.

David has made no other calls on XERS in the last 4 months.



There are 2 other peers that have a rating on XERS. Out of the 2 peers that are also analyzing XERS, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $5 on, Thursday, March 28th, 2024
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 7th, 2024